학술논문
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series
Document Type
Article
Author
Orlandi, A.; Iattoni, E.; Di Dio, C.; Palazzo, A.; Garufi, G.; Indellicati, G.; Cassano, A.; Bria, E.; Tortora, G.; Pizzuti, L.; Fabi, A.; Vici, P.; Fabbri, A.; Alesini, D.; Botticelli, A.; Magri, V.; Naso, G.; Marchetti, P.; Carbognin, L.; Paris, I.; Vaccaro, A.; Moscetti, L.; Franceschini, G.; Giannarelli, D.
Source
In: Journal of Personalized Medicine . (Journal of Personalized Medicine, December 2020, 10(4):1-11)
Subject
Language
English
ISSN
20754426